Revolution Medicines, Inc. (RVMD)
Revolution Medicines develops cancer drug candidates from its base in Redwood City, California. It last closed at $162.69 on Nov 17, down 2.50% on the day. RVMD last reported earnings on Wed, Nov 4, 2026. The average 12-month price target from 17 analysts is $270.18 (+66.1% from the last close), with a high of $350.00 and a low of $179.00. Analyst consensus is Strong Buy, based on the latest ratings from 17 firms (16 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 4 whale options trades in RVMD, 25% of them bullish and 75% bearish. In the past 30 days there were 16 dark pool prints totaling $15.2M, the largest $2.6M.
Key Stats
Last 12 monthsNot reported for this period.
From RVMD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 17 analysts who set a price target on RVMD in the past 90 days. The average target is $270.18, with a high of $350.00 and a low of $179.00, compared with the last close of $162.69.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 13 | Morgan Stanley | Target lowered | Buy | $255 → $247 |
| Nov 6 | HC Wainwright & Co. | Target raised | Buy | $280 → $350 |
| Nov 5 | TD Cowen | Target raised | Buy | $250 → $270 |
| Nov 5 | RBC Capital | Target raised | Buy | $260 → $321 |
| Nov 5 | Piper Sandler | Maintained | Buy | $222 |
Technical Analysis
The stock is 14% below its 20 day and 18% below its 50 day average. It is 1% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 35), near oversold. The nearest support is the 200 day average at $160.55, and the nearest resistance the Pivot at $164.12.
| RSI (14) | 35.40 | Weak, oversold below 30 | Neutral |
| MACD | -6.02 | Below its signal line | Bearish |
| Stochastic | 4.4 | Near the bottom of its range | Oversold |
| ADX (14) | 20.7 | Weak trend | |
| Williams %R | -97.9 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -220.3 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −16.2% | Change over 10 sessions | Bearish |
| ATR (14) | $9.55 | Typical daily range, 5.9% of price |
| RSI (14) | 43.53 | Middle of its range | Neutral |
| MACD | 7.54 | Below its signal line | Bearish |
| Stochastic | 14.0 | Near the bottom of its range | Oversold |
| ADX (14) | 39.0 | Trending up | |
| Williams %R | -98.4 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -201.2 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −20.2% | Change over 10 sessions | Bearish |
| ATR (14) | $18.53 | Typical daily range, 11.4% of price |
What happened before
See how RVMD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How RVMD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
Whale Options Flow
90DNo whale options trades in RVMD in the last 90 days.
Dark Pool
30DRVMD Institutional Ownership
Full report →- ▲453 buying vs 269 selling
- ▼Held by funds -1.0 pts
- ▲Funds holding +62
- ▲Superinvestors: 3 added, 1 cut
- ▼Put/call 0.52 to 1.13
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 757 | 695 | +8.9% |
| In funds' top 10 | 37 | 47 | −21.3% |
| Held by funds | 98.1% | 99.1% | −1.0 pts |
| New / increased | 141 / 312 | 237 / 243 | −5.6% |
| Reduced / sold out | 197 / 72 | 148 / 64 | +26.9% |
| Put/call ratio | 1.13 | 0.52 | +115.2% |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RVMD is in one of them and how their past RVMD trades turned out.
RVMD News & Analysis
All StreetAlpha news →RVMD Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Scott A KuporExecutive branch | Sell | $1K – $15K | Jul 30, 2026 | Sep 30, 2026 | 62 d |
| Donald J TrumpExecutive branch | Buy | $1K – $15K | Jul 17, 2026 | Sep 22, 2026 | 67 d |
| Donald J TrumpExecutive branch | Sell | $50K – $100K | May 18, 2026 | Jul 1, 2026 | 44 d |
| Donald J TrumpExecutive branch | Buy | $1K – $15K | Mar 23, 2026 | May 14, 2026 | 52 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Revolution Medicines
Revolution Medicines is a biotechnology company based in Redwood City, California. It is developing drug candidates for cancer, including RAS(ON) inhibitors, which are being tested alone and in combination with other cancer therapies. None of its product candidates has received regulatory approval yet, so it does not currently sell products. Its work is aimed at cancer patients and the doctors who treat them.
- Headquarters
- Redwood City, CA
- Founded
- 2014
- Website
- revmed.com ↗




